Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-10 12:17 pm Purchase |
2021-08-10 | 13G | Tango Therapeutics, Inc. TNGX |
GILEAD SCIENCES INC. GILD |
4,854,443 5.500% |
4,854,443 (New Position) |
Filing History |
| 2021-02-16 3:46 pm Unchanged |
2021-02-16 | 13G | Gilead Sciences, Inc. GILD |
Capital Research Global Investors | 121,672,399 9.700% |
0 (Unchanged) |
Filing History |
| 2021-02-16 1:27 pm Purchase |
2021-02-16 | 13G | Gilead Sciences, Inc. GILD |
Capital Research Global Investors | 121,672,399 9.700% |
36,539,514 (+42.92%) |
Filing History |
| 2021-02-12 4:36 pm Purchase |
2020-12-31 | 13G | HOOKIPA Pharma Inc. HOOK |
GILEAD SCIENCES INC. GILD |
209,280 7.200% |
42,553 (+25.52%) |
Filing History |
| 2021-02-10 10:57 am Sale |
2020-12-31 | 13G | Gilead Sciences, Inc. GILD |
The Vanguard Group | 102,787,017 8.200% |
-984,831 (-0.95%) |
Filing History |
| 2021-02-02 4:51 pm Sale |
2021-01-31 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC. GILD |
22,723,156 35.000% |
-6,775,268 (-22.97%) |
Filing History |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
111,183,334 8.900% |
4,709,740 (+4.42%) |
Filing History |
| 2020-10-26 4:33 pm Purchase |
2020-10-16 | 13G | Jounce Therapeutics, Inc. JNCE |
GILEAD SCIENCES INC. GILD |
5,539,727 13.900% |
5,539,727 (New Position) |
Filing History |
| 2020-07-17 2:01 pm Purchase |
2020-07-08 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC. GILD |
29,498,424 35.000% |
29,498,424 (New Position) |
Filing History |